Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
171
currently held
Exits tracked
127
hand-checked
Sectors covered
1
across the portfolio
Countries covered
31
from every market
241 companies matching · Page 3 of 5
Neftys Pharma
For Talents Transmission
Sector
Pharma
InvestorFor Talents Transmission
Entry
2022
Hold
4yr
Owners
3
Recipharm
CM-CIC Debt Fund 3
Sector
Pharma
InvestorCIC Private Debt
Entry
2021
Hold
5yr
Owners
3
ROTOP Pharmaka
GENUI III
Sector
Pharma
InvestorGENUI
Entry
2024
Hold
2yr
Owners
3
Biogaran
Bpifrance
Sector
Pharma
InvestorBpifrance Investissement
Entry
2025
Hold
1yr
Owners
2
Ceva Sante Animale
MED II
Sector
Pharma
InvestorARCHIMED
Entry
2025
Hold
1yr
Owners
2
Gen Orph
Crédit Mutuel Equity
Sector
Pharma
InvestorCrédit Mutuel Equity
Entry
2014
Hold
12yr
Owners
2
Naogen Pharma
Altur Investissement
Sector
Pharma
InvestorAltur Investissement
Entry
2018
Hold
8yr
Owners
2
Ojer Pharma
Easo Ventures II
Sector
Pharma
InvestorEaso Ventures
Entry
2014
Hold
12yr
Owners
2
SGH Medical Pharma
Mérieux Participations 2
Sector
Pharma
InvestorMerieux Equity Partners
Entry
2018
Hold
8yr
Owners
2
Simtra BioPharma Solutions
Latin American Private Equity Fund VII
Sector
Pharma
InvestorAdvent International
Entry
–
Owners
2
4TEEN4 Pharmaceuticals GmbH
Fruehphasen- und Wachstumsfonds Brandenburg
Sector
Pharma
InvestorBrandenburg Kapital
Entry
2019
Hold
7yr
Addvance Group
capiton V
Sector
Pharma
Investorcapiton
Entry
2021
Hold
5yr
Advanthera
Columbus Life Sciences Fund IV
Sector
Pharma
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
Advantice Health
TA XIV
Sector
Pharma
InvestorTA Associates
Entry
–
ADVICENNE
IRDInov
Sector
Pharma
InvestorIrdi Capital-Investissement
Entry
2017
Hold
9yr
Aileens Pharma
Panakes Fund I
Sector
Pharma
InvestorPanakes Partners SGR
Entry
2018
Hold
8yr
ALGIAX
HTGF II
Sector
Pharma
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2012
Hold
14yr
Alvogen
CVC Capital Partners Portfolio
Sector
Pharma
InvestorCVC Capital Partners
Entry
–
Apurano
Capmont Private Equity
Sector
Pharma
InvestorCapmont
Entry
2023
Hold
3yr
Ardena
GHO Capital Fund II LP
Sector
Pharma
InvestorGHO Capital
Entry
2020
Hold
6yr
Aston Particle Technologies
DSW Ventures
Sector
Pharma
InvestorDSW Venture Capital
Entry
2022
Hold
4yr
Avacare Health
Amethis Fund II
South Africa
Sector
Pharma
InvestorAmethis
Entry
2021
Hold
5yr
Axience
Motion Equity Partners Fund
Sector
Pharma
InvestorMotion Equity Partners
Entry
2024
Hold
2yr
Biofrontera AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
Sector
Pharma
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2019
Hold
7yr
Bioluz
IDES (Institut de Développement de l’Economie Sociale)
Sector
Pharma
InvestorESFIN GESTION
Entry
2013
Hold
13yr
BMG Pharma
Friulia Balance Sheet
Sector
Pharma
InvestorFriulia
Entry
2021
Hold
5yr
Cambrex
Permira VII
Sector
Pharma
InvestorPermira
Entry
2019
Hold
7yr
CANbridge
General Atlantic
China
Sector
Pharma
InvestorGeneral Atlantic
Entry
–
Chanelle Pharma
Exponent Private Equity Partners V
Sector
Pharma
InvestorExponent Private Equity
Entry
2024
Hold
2yr
Cheplapharm
CIC Debt Fund 4
Sector
Pharma
InvestorCIC Private Debt
Entry
2022
Hold
4yr
CORXEL
Leaps by Bayer
China
Sector
Pharma
InvestorLeaps by Bayer
Entry
2024
Hold
2yr
CSO Pharmitalia
Star III Private Equity Fund
Sector
Pharma
InvestorStar Capital SGR
Entry
2016
Hold
10yr
Cuantum Medical Cosmetics
Inveready Biotech II
Sector
Pharma
InvestorInveready Asset Management
Entry
2015
Hold
11yr
curia
The Carlyle Group Portfolio
Sector
Pharma
InvestorThe Carlyle Group
Entry
–
Demecan Holding GmbH
Technologiefonds Hessen
Sector
Pharma
InvestorBMH Beteiligungsmanagement Hessen
Entry
2021
Hold
5yr
Develco Pharma
SHS V
Sector
Pharma
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2020
Hold
6yr
Ergomed
Permira VIII
Sector
Pharma
InvestorPermira
Entry
2023
Hold
3yr
Essential Pharma
Penta Capital Fund I
Sector
Pharma
InvestorPenta Capital
Entry
2025
Hold
1yr
Farmalider
MCH Iberian Capital Fund V
Sector
Pharma
InvestorMCH Private Equity Investments
Entry
2023
Hold
3yr
Galenicum
Peninsula Investments Europe
Sector
Pharma
InvestorPeninsula Capital
Entry
2021
Hold
5yr
Ideal Cures Pvt. Ltd.
TA Associates Portfolio
India
Sector
Pharma
InvestorTA Associates
Entry
–
IRAB
MED Rise
Sector
Pharma
InvestorARCHIMED
Entry
2026
Hold
0yr
Laboratoire Polidis
Siparex Entrepreneurs 6
Sector
Pharma
InvestorSiparex
Entry
2025
Hold
1yr
Laxxon Medical
Evonik Venture Capital
Sector
Pharma
InvestorEvonik Venture Capital
Entry
2022
Hold
4yr
leon-nanodrugs GmbH
BayBG Venture Capital
Sector
Pharma
InvestorBayBG Bayerische Beteiligungsgesellschaft
Entry
2020
Hold
6yr
MAYOLY SPINDLER
CAPZA Flex Equity Mid-Market I
Sector
Pharma
InvestorCapza
Entry
2022
Hold
4yr
Medical Plants
Realza Capital Fund II
Sector
Pharma
InvestorRealza Capital
Entry
2021
Hold
5yr
Millicent Pharma Limited
Carlyle Global Infrastructure Opportunity Fund
Sector
Pharma
InvestorThe Carlyle Group
Entry
–
MiP Pharma
capiton VI
Sector
Pharma
Investorcapiton
Entry
2020
Hold
6yr
MITEM Pharma
TechLife Capital I
Sector
Pharma
InvestorTechLife Capital
Entry
2020
Hold
6yr